Attendo AB (publ) provides financed care services in Sweden, Finland, Norway, and Denmark.
Reasonable growth potential with imperfect balance sheet.
Share Price & News
How has Attendo's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 7AT has not had significant price volatility in the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: 7AT underperformed the German Healthcare industry which returned -0.3% over the past year.
Return vs Market: 7AT underperformed the German Market which returned 6.1% over the past year.
Price Volatility Vs. Market
How volatile is Attendo's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Attendo undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 7AT (€4.68) is trading above our estimate of fair value (€1.63)
Significantly Below Fair Value: 7AT is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 7AT is poor value based on its PE Ratio (100.1x) compared to the Healthcare industry average (36.9x).
PE vs Market: 7AT is poor value based on its PE Ratio (100.1x) compared to the German market (20.2x).
Price to Earnings Growth Ratio
PEG Ratio: 7AT is poor value based on its PEG Ratio (1.7x)
Price to Book Ratio
PB vs Industry: 7AT is good value based on its PB Ratio (1.4x) compared to the DE Healthcare industry average (1.5x).
How is Attendo forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 7AT's forecast earnings growth (58.5% per year) is above the savings rate (-0.4%).
Earnings vs Market: 7AT's earnings (58.5% per year) are forecast to grow faster than the German market (13% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 7AT's revenue (6.4% per year) is forecast to grow faster than the German market (5.1% per year).
High Growth Revenue: 7AT's revenue (6.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 7AT's Return on Equity is forecast to be low in 3 years time (6%).
How has Attendo performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 7AT has high quality earnings.
Growing Profit Margin: 7AT's current net profit margins (0.7%) are lower than last year (2.9%).
Past Earnings Growth Analysis
Earnings Trend: 7AT's earnings have declined by -8.9% per year over the past 5 years.
Accelerating Growth: 7AT's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 7AT had negative earnings growth (-74.8%) over the past year, making it difficult to compare to the Healthcare industry average (6.2%).
Return on Equity
High ROE: 7AT's Return on Equity (1.4%) is considered low.
How is Attendo's financial position?
Financial Position Analysis
Short Term Liabilities: 7AT's short term assets (SEK2.2B) do not cover its short term liabilities (SEK2.7B).
Long Term Liabilities: 7AT's short term assets (SEK2.2B) do not cover its long term liabilities (SEK11.8B).
Debt to Equity History and Analysis
Debt Level: 7AT's debt to equity ratio (48.7%) is considered high.
Reducing Debt: 7AT's debt to equity ratio has reduced from 205.6% to 48.7% over the past 5 years.
Debt Coverage: 7AT's debt is well covered by operating cash flow (63.4%).
Interest Coverage: 7AT's interest payments on its debt are not well covered by EBIT (1.3x coverage).
Inventory Level: 7AT has a high level of physical assets or inventory.
Debt Coverage by Assets: 7AT's debt is not covered by short term assets (assets are 0.8x debt).
What is Attendo's current dividend yield, its reliability and sustainability?
Forecast Dividend Yield
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 7AT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate 7AT's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 7AT's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 7AT's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: 7AT is not paying a notable dividend for the German market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 7AT's dividend in 3 years as they are not forecast to pay a notable one for the German market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Martin Tivéus (49yo)
Mr. Martin Folke Tivéus has been the Chief Executive Officer at Attendo AB (publ) since September, 2018 and has been its President since 2018. Mr. Tivéus is Director of Telia Company AB since March 2018. H ...
CEO Compensation Analysis
Compensation vs Market: Martin's total compensation ($USD10.89K) is below average for companies of similar size in the German market ($USD1.20M).
Compensation vs Earnings: Insufficient data to compare Martin's compensation with company performance.
|CEO & President||1.4yrs||kr13.23m||no data|
|Chief Financial Officer||1.9yrs||no data||no data|
|Communications & IR Director||3.8yrs||no data||0.015% SEK119.4k|
|Head of Community Communications||0yrs||no data||no data|
|Head of Corporate Control||0yrs||no data||no data|
Experienced Management: 7AT's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
|Independent Director||13.1yrs||kr410.00k||0.78% SEK6.1m|
|Independent Director||3.8yrs||kr335.00k||0.0068% SEK53.3k|
|Chairman of the Board||2.8yrs||kr1.03m||0.012% SEK97.9k|
|Independent Director||1.8yrs||kr335.00k||no data|
|Employee Representative Director||0yrs||no data||0.000040% SEK315.0|
|Independent Director||3.8yrs||kr485.00k||0.0062% SEK49.0k|
|Independent Director||3.8yrs||kr660.00k||0.0037% SEK29.4k|
|Alternate Representative Director||3.1yrs||no data||no data|
|Director||0yrs||no data||no data|
|Director||0yrs||no data||no data|
Experienced Board: 7AT's board of directors are considered experienced (3.8 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: 7AT insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Attendo AB (publ)'s company bio, employee growth, exchange listings and data sources
- Name: Attendo AB (publ)
- Ticker: 7AT
- Exchange: DB
- Founded: 1985
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: kr8.326b
- Listing Market Cap: kr787.378m
- Shares outstanding: 160.89m
- Website: https://www.attendo.com
Number of Employees
- Attendo AB (publ)
- Vendevägen 85
- Stockholm County
- 182 91
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|ATT||OM (OMX Nordic Exchange Stockholm)||Yes||Class A Shares||SE||SEK||Nov 2015|
|7AT||DB (Deutsche Boerse AG)||Yes||Class A Shares||DE||EUR||Nov 2015|
|ATTS||BATS-CHIXE (BATS 'Chi-X Europe')||Yes||Class A Shares||GB||SEK||Nov 2015|
|0RCY||LSE (London Stock Exchange)||Yes||Class A Shares||GB||SEK||Nov 2015|
Attendo AB (publ) provides financed care services in Sweden, Finland, Norway, and Denmark. The company offers care services for older people in nursing homes and home care. It also provides care services for people with disabilities; homes for children with special needs; consultant supported family home care services; crisis and acute accommodations; substance abuse care services; and care homes for people with neuropsychiatric conditions. The company was founded in 1985 and is headquartered in Danderyd, Sweden.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/02/25 23:11|
|End of Day Share Price||2020/02/25 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.